Inovio Pharmaceuticals (INO) Change in Acquisitions & Divestments (2010 - 2026)

Inovio Pharmaceuticals has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $4.6 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.9 million (down 75.1% YoY) and the FY2025 annual result came in at $14.3 million, down 89.11% from the prior year.
• Change in Acquisitions & Divestments improved to $4.6 million in Q1 2026 per INO's latest filing, from -$4.9 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $123.1 million in Q1 2022 and troughed at -$4.9 million in Q4 2025.
• A 5-year average of $49.7 million and a median of $43.9 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 24293.23% in 2022, then plunged 170.97% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $99.1 million in 2022, then slumped by 50.56% to $49.0 million in 2023, then tumbled by 85.83% to $6.9 million in 2024, then slumped by 170.97% to -$4.9 million in 2025, then jumped by 193.55% to $4.6 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $4.6 million, -$4.9 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.